Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mcphy Energy | M6P | Nov 25, 2024 | 1.13 | -1.74 |
MDU Resources Group, Inc. | MRE | Nov 25, 2024 | 19.10 | +3.80 |
Mears Group PLC | MM7 | Nov 25, 2024 | 4.36 | +0.11 |
Mebuki Financial Group Inc. | 5EE | Nov 25, 2024 | 4.02 | +0.50 |
Medallion Financial Corp. | MD5 | Nov 25, 2024 | 8.80 | 0.00 |
Medapp S.A. | WQ1 | Nov 25, 2024 | 0.03 | -0.61 |
Medaro Mining | 1ZY0 | Nov 25, 2024 | 0.09 | +2.33 |
MEDBRIGHT AI INVTS INC. | Y30 | Nov 25, 2024 | 0.00 | -50.00 |
MedCap | 61MA | Nov 25, 2024 | 48.60 | +4.63 |
Medesis Pharma S.A. | 76D | Nov 25, 2024 | 0.34 | -2.86 |
Medexus Pharmaceuticals Inc | P731 | Nov 25, 2024 | 1.61 | +16.67 |
Media and Games Invest SE | M8G | Nov 25, 2024 | 4.00 | +0.38 |
Mediaco Holding Inc. - Class A | 3WX | Nov 25, 2024 | 1.24 | +4.20 |
MEDIAN POLSKA S.A. ZY-,10 | GY3 | Nov 25, 2024 | 0.15 | +0.66 |
Median Technologies | 4ZG | Nov 25, 2024 | 3.37 | -0.44 |
Medibank Private Limited | MPV | Nov 25, 2024 | 2.28 | +0.89 |
Medical Facilities Corp | 31F | Nov 25, 2024 | 10.70 | -0.93 |
Medical Properties Trust Inc | M3P | Nov 25, 2024 | 4.22 | +3.86 |
Mediclin AG | MED | Nov 25, 2024 | 2.46 | 0.00 |
Medicover B | 5M0B | Nov 25, 2024 | 15.22 | +2.98 |
Medicure Inc | NGQ1 | Nov 25, 2024 | 0.60 | 0.00 |
MEDICUS PHARMA LTD. | N46 | Nov 25, 2024 | 0.57 | 0.00 |
MEDICUS PHARMA LTD. | N460 | Nov 25, 2024 | 2.73 | 0.00 |
MEDIFAST INC | MDF | Nov 25, 2024 | 17.47 | +2.61 |
Medigene AG | MDG1 | Nov 25, 2024 | 1.50 | -1.96 |
Medimi | 79T | Nov 25, 2024 | 0.00 | 0.00 |
Medincell S.A. | MEB | Nov 25, 2024 | 17.36 | +2.72 |
MEDIOBANCA S.P.A.UNSP.ADR | ME90 | Nov 25, 2024 | 13.80 | +0.73 |
Mediobanca SpA | ME9 | Nov 25, 2024 | 13.97 | +0.65 |
Medion AG | MDN | Nov 25, 2024 | 14.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.